FDA Commissioner Califf Says Business Of Health Is Booming In U.S. But Patients’ Outcomes Aren’t Improving

Forbes May 4, 2022
Joshua Cohen

At a hearing last month, Food and Drug Administration (FDA) Commissioner Robert Califf pointed to the fact that the U.S. is one of the greatest inventors in the world of medicines and other healthcare technologies, but in last place for life expectancy among other high-income countries.

What’s conspicuous about this factoid is that the U.S. spends the most in the world on healthcare – both in absolute and relative (per capita) terms. Of course, the provision of healthcare isn’t the sole cause of rising life expectancy. Other factors play a role, too, including baseline characteristics of health, such as levels of obesity and socioeconomic determinants of health. Nonetheless, healthcare contributes greatly to improvement in life expectancy. As such, clearly, something’s...

Today's Sponsors

Today's Sponsor